GS
Graig Suvannavejh Mizuho Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
41
Avg Return
Past Year
Past Year
35%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
77.3%
Neutral
22.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $205 |
106%
upside
| 1 | +10% |
0
%
| 7 Jan ‘26 12 days ago |
|
|
|
Outperform
Maintained
| $5 |
48%
downside
| 1 | +188% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $54 |
48%
upside
| 3 | +45% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Outperform
Upgraded
| $194 |
25%
upside
| 2 | +0.71% |
0
%
| 2 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $256 |
59%
upside
| 4 | +24% |
0
%
| 1 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $46 |
27%
upside
| 6 | +1.2% |
0
%
| 1 Dec ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $100 |
41%
upside
| 1 | -7.7% |
0
%
| 20 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $23 |
134%
upside
| 1 | -4.7% |
0
%
| 19 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $56 |
21%
downside
| 1 | – |
–
| 18 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $46 |
28%
upside
| 2 | +20% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $202 |
14%
upside
| 5 | +12% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $19 |
5%
downside
| 4 | – |
–
| 3 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $4 |
117%
upside
| 1 | – |
–
| 12 Sep ‘25 4 months ago |
|
|
|
Outperform
Initiated
| $30 |
4,344%
upside
| 1 | -95% |
0
%
| 8 Sep ‘25 4 months ago |
|
|
|
Outperform
Upgraded
| $3.50 |
90%
upside
| 1 | +4.5% |
0
%
| 28 Jul ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $5 |
148%
upside
| 1 | +39% |
0
%
| 16 Jul ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $12 | – | 1 | +65% |
0
%
| 26 Jun ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $0.5000 | – | 1 | -63% |
–
| 26 Jun ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $10 |
118%
upside
| 1 | +152% |
0
%
| 18 Jun ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $11 |
37%
upside
| 1 | +122% |
0
%
| 20 May ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $26 |
72%
upside
| 1 | +164% |
0
%
| 16 May ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $8 |
44%
downside
| 2 | +125% |
0
%
| 14 May ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $33 |
1%
downside
| 1 | – |
–
| 7 Apr ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| $132 |
0%
upside
| 1 | +36% |
–
| 24 Feb ‘25 10 months ago |
|